Clearstead Advisors’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-198
| Closed | -$15K | – | 3686 |
|
|
2026
Q1 | $15K | Sell |
198
-2,020
| -91% | -$152K | ﹤0.01% | 1507 |
|
|
2025
Q4 | $165K | Buy |
2,218
+1,612
| +266% | +$118K | ﹤0.01% | 969 |
|
|
2025
Q3 | $40.9K | Buy |
606
+11
| +2% | +$730 | ﹤0.01% | 1340 |
|
|
2025
Q2 | $38.8K | Buy |
595
+239
| +67% | +$14.3K | ﹤0.01% | 1372 |
|
|
2025
Q1 | $22K | Buy |
356
+53
| +17% | +$3.51K | ﹤0.01% | 1402 |
|
|
2024
Q4 | $21.8K | Hold |
303
| – | – | ﹤0.01% | 1357 |
|
|
2024
Q3 | $24.7K | Hold |
303
| – | – | ﹤0.01% | 1370 |
|
|
2024
Q2 | $22.5K | Buy |
+303
| New | +$22.7K | ﹤0.01% | 1342 |
|
|
2024
Q1 | – | Sell |
-17
| Closed | -$1.22K | – | 1580 |
|
|
2023
Q4 | $1.22K | Buy |
+17
| New | +$1.18K | ﹤0.01% | 1378 |
|
|
2023
Q2 | – | Sell |
-15
| Closed | -$1.21K | – | 1405 |
|
|
2023
Q1 | $1.21K | Buy |
+15
| New | +$1.21K | ﹤0.01% | 1205 |
|
|
2022
Q3 | – | Sell |
-59
| Closed | -$4K | – | 1295 |
|
|
2022
Q2 | $4K | Buy |
+59
| New | +$4.38K | ﹤0.01% | 1028 |
|
|
2021
Q3 | – | Sell |
-21
| Closed | -$1K | – | 1329 |
|
|
2021
Q2 | $1K | Buy |
+21
| New | +$1.4K | ﹤0.01% | 1155 |
|
Other funds holding HOLX
Clearstead Advisors's HOLX Position: Q2 2026 in Review
Clearstead Advisors sold out of Hologic (HOLX) in Q2 2026, closing a stake of 198 shares — an estimated $15K sold.
Clearstead Advisors first reported a position in HOLX in Q2 2021 and held it in 12 quarters. The position peaked at $165K in Q4 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Clearstead Advisors reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Clearstead Advisors sold 198 Hologic shares in Q2 2026, an estimated $15K.
- Clearstead Advisors first reported a position in Hologic in Q2 2021 and held it in 12 quarters.
- Clearstead Advisors's Hologic position peaked at $165K in Q4 2025.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.